NMRA insider transaction filings
Neumora Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen NMRA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | BERNS PAUL L — See Remarks, Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Aurora Daljit Singh — See Remarks | Option exercise (M): 67,741 @ $0.72 · Sale (S): 67,741 @ $1.51 · Option exercise (M): 21,685 @ $0.72 · Option exercise (M): 45,026 @ $0.72 · Sale (S): 66,711 @ $1.51 · Option exercise (M): 20,553 @ $0.72 · +9 more | EDGAR |
| 2026-08-21 | 4 | Milligan Michael Lee — See Remarks | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Duncan Jason — See Remarks | Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Pinto Joshua — President & CEO, Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Aurora Daljit Singh — See Remarks | Option exercise (M): 40,890 @ $0.72 · Option exercise (M): 15,355 @ $0.72 · Option exercise (M): 1,424 @ $0.72 · Option exercise (M): 1 @ $0.72 · Sale (S): 57,670 @ $1.51 · Sale (S): 34,020 @ $1.49 · +23 more | EDGAR |
| 2026-05-29 | 4 | Halawa Alaa — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Ho Maykin — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Piacquad David — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Burow Kristina — Director, 10% owner | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Fust Matthew K — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Pinto Joshua — President | Sale (S): 5,967 @ $3.54 | EDGAR |
| 2026-02-19 | 4 | Milligan Michael Lee — See Remarks | Sale (S): 1,436 @ $3.56 | EDGAR |
| 2026-02-19 | 4 | Aurora Daljit Singh — See Remarks | Sale (S): 6,165 @ $3.56 | EDGAR |
| 2026-02-19 | 4 | BERNS PAUL L — See Remarks, Director | Sale (S): 9,819 @ $3.51 | EDGAR |
| 2026-01-09 | 4 | Milligan Michael Lee — See Remarks | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Pinto Joshua — President | Grant/award (A): 1,200,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Aurora Daljit Singh — See Remarks | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Duncan Jason — See Remarks | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | BERNS PAUL L — See Remarks, Director | Grant/award (A): 1,650,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Aurora Daljit Singh — See Remarks | Sale (S): 114,703 @ $2.68 | EDGAR |
| 2025-10-29 | 4 | Burow Kristina — Director, 10% owner | Purchase (P): 1,915,700 @ $2.61 | EDGAR |
| 2025-10-29 | 4 | ARCH Venture Partners X, LLC — 10% owner ARCH Venture Fund X, L.P. — 10% owner ARCH Venture Partners X, L.P. — 10% owner ARCH Venture Fund X Overage, L.P. — 10% owner ARCH Venture Partners X Overage, L.P. — 10% owner ARCH Venture Partners VII, LLC — 10% owner ARCH Venture Partners VII, L.P. — 10% owner ARCH Venture Fund VII, L.P. — 10% owner ARCH Venture Partners VIII, LLC — 10% owner ARCH Venture Fund VIII Overage, L.P. — 10% owner | Purchase (P): 1,915,700 @ $2.61 | EDGAR |
| 2025-10-29 | 4 | ARCH Venture Partners XII, LLC — 10% owner ARCH Venture Partners XII, L.P. — 10% owner ARCH Venture Fund XII, L.P. — 10% owner CRANDELL KEITH — 10% owner GILLIS STEVEN — 10% owner NELSEN ROBERT — 10% owner BYBEE CLINTON — 10% owner | Purchase (P): 1,915,700 @ $2.61 | EDGAR |
| 2025-05-30 | 4 | Milligan Michael Lee — See Remarks | Disposition to issuer (D): 85,391 (derivative) · Disposition to issuer (D): 38,234 (derivative) · Disposition to issuer (D): 28,675 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 85,391 (derivative) · +4 more | EDGAR |
| 2025-05-30 | 4 | Halawa Alaa — Director | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Pinto Joshua — President | Disposition to issuer (D): 223,034 (derivative) · Disposition to issuer (D): 270,828 (derivative) · Disposition to issuer (D): 223,034 (derivative) · Disposition to issuer (D): 720,084 (derivative) · Disposition to issuer (D): 127,448 (derivative) · Disposition to issuer (D): 170,000 (derivative) · +8 more | EDGAR |
| 2025-05-30 | 4 | Aurora Daljit Singh — See Remarks | Disposition to issuer (D): 40,890 (derivative) · Disposition to issuer (D): 137,538 (derivative) · Disposition to issuer (D): 207,901 (derivative) · Disposition to issuer (D): 136,210 (derivative) · Disposition to issuer (D): 72,221 (derivative) · Disposition to issuer (D): 29,737 (derivative) · +10 more | EDGAR |
| 2025-05-30 | 4 | Duncan Jason — See Remarks | Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 500,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 500,000 (derivative) | EDGAR |
| 2025-05-30 | 4 | Ho Maykin — Director | Disposition to issuer (D): 95,586 (derivative) · Disposition to issuer (D): 27,802 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 95,586 (derivative) · Grant/award (A): 27,802 (derivative) · Grant/award (A): 28,571 (derivative) · +1 more | EDGAR |
| 2025-05-30 | 4 | Piacquad David — Director | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Burow Kristina — Director, 10% owner | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Fust Matthew K — Director | Disposition to issuer (D): 85,586 (derivative) · Disposition to issuer (D): 27,802 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 85,586 (derivative) · Grant/award (A): 27,802 (derivative) · Grant/award (A): 28,571 (derivative) · +1 more | EDGAR |
| 2025-05-30 | 4 | BERNS PAUL L — See Remarks, Director | Disposition to issuer (D): 497,049 (derivative) · Disposition to issuer (D): 955,864 (derivative) · Disposition to issuer (D): 342,500 (derivative) · Disposition to issuer (D): 2,000,000 (derivative) · Grant/award (A): 497,049 (derivative) · Grant/award (A): 955,864 (derivative) · +2 more | EDGAR |
| 2025-05-23 | 4 | Pinto Joshua — President | Gift (G): 13,202 @ $0 · Gift (G): 13,202 @ $0 | EDGAR |
| 2025-02-20 | 4 | Milligan Michael Lee — See Remarks | Sale (S): 1,978 @ $1.69 | EDGAR |
| 2025-02-20 | 4 | Lenz Robert A. — Head of R&D | Sale (S): 5,614 @ $1.67 | EDGAR |
| 2025-02-20 | 4 | Pinto Joshua — President | Sale (S): 8,048 @ $1.67 | EDGAR |
| 2025-02-20 | 4 | Aurora Daljit Singh — Chief Strategy Officer | Sale (S): 8,565 @ $1.68 | EDGAR |
| 2025-02-20 | 4 | BERNS PAUL L — See Remarks, Director | Sale (S): 13,871 @ $1.69 | EDGAR |
| 2025-02-18 | 4 | Milligan Michael Lee — See Remarks | Grant/award (A): 400,000 (derivative) @ $0 · Disposition to issuer (D): 85,391 (derivative) · Disposition to issuer (D): 38,234 (derivative) · Disposition to issuer (D): 28,675 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Grant/award (A): 85,391 (derivative) · +3 more | EDGAR |
| 2025-02-18 | 4 | Lenz Robert A. — Head of R&D | Disposition to issuer (D): 502,934 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Grant/award (A): 502,934 (derivative) · Grant/award (A): 100,000 (derivative) | EDGAR |
| 2025-02-18 | 4 | Pinto Joshua — President | Grant/award (A): 3,000,000 (derivative) @ $0 · Disposition to issuer (D): 223,034 (derivative) · Disposition to issuer (D): 270,828 (derivative) · Disposition to issuer (D): 223,034 (derivative) · Disposition to issuer (D): 720,084 (derivative) · Disposition to issuer (D): 127,448 (derivative) · +7 more | EDGAR |
| 2025-02-18 | 4 | Halawa Alaa — Director | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) | EDGAR |
| 2025-02-18 | 4 | Aurora Daljit Singh — See Remarks | Grant/award (A): 1,000,000 (derivative) @ $0 · Disposition to issuer (D): 40,890 (derivative) · Disposition to issuer (D): 137,538 (derivative) · Disposition to issuer (D): 207,901 (derivative) · Disposition to issuer (D): 136,210 (derivative) · Disposition to issuer (D): 72,221 (derivative) · +9 more | EDGAR |
| 2025-02-18 | 4 | Duncan Jason — See Remarks | Grant/award (A): 500,000 (derivative) @ $0 · Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 400,000 (derivative) | EDGAR |
| 2025-02-18 | 4 | Ho Maykin — Director | Disposition to issuer (D): 95,586 (derivative) · Disposition to issuer (D): 27,802 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 95,586 (derivative) · Grant/award (A): 27,802 (derivative) · Grant/award (A): 28,571 (derivative) | EDGAR |
| 2025-02-18 | 4 | Piacquad David — Director | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) | EDGAR |
| 2025-02-18 | 4 | Burow Kristina — Director, 10% owner | Disposition to issuer (D): 46,455 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 46,455 (derivative) · Grant/award (A): 28,571 (derivative) | EDGAR |
| 2025-02-18 | 4 | Fust Matthew K — Director | Disposition to issuer (D): 85,586 (derivative) · Disposition to issuer (D): 27,802 (derivative) · Disposition to issuer (D): 28,571 (derivative) · Grant/award (A): 85,586 (derivative) · Grant/award (A): 27,802 (derivative) · Grant/award (A): 28,571 (derivative) | EDGAR |
Recent 8-K events — Neumora Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ? 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-21 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NMRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →